The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 29, 2025

Filed:

Dec. 15, 2023
Applicant:

Livanova Usa, Inc., Houston, TX (US);

Inventors:

Imad Libbus, St. Paul, MN (US);

Bruce H. KenKnight, Maple Grove, MN (US);

Badri Amurthur, Los Gatos, CA (US);

Scott R. Stubbs, Maple Grove, MN (US);

Assignee:

LivaNova USA, Inc., Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2005.12); A61B 5/349 (2020.12); A61B 5/355 (2020.12); A61N 1/05 (2005.12); A61N 1/37 (2005.12); A61N 1/372 (2005.12); G16H 20/30 (2017.12); G16H 20/40 (2017.12); G16H 40/20 (2017.12); G16H 40/63 (2017.12); G16Z 99/00 (2018.12);
U.S. Cl.
CPC ...
A61N 1/36139 (2012.12); A61B 5/349 (2020.12); A61B 5/355 (2020.12); A61N 1/0551 (2012.12); A61N 1/36114 (2012.12); A61N 1/36132 (2012.12); A61N 1/3615 (2012.12); A61N 1/36167 (2012.12); A61N 1/3702 (2012.12); A61N 1/37223 (2012.12); A61N 1/37235 (2012.12); G16H 20/30 (2017.12); G16H 20/40 (2017.12); G16H 40/20 (2017.12); G16H 40/63 (2017.12); G16Z 99/00 (2019.01);
Abstract

Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. Between titration sessions one or more parameters, such as, for example, an acclimation interval, may be adjusted based on the patient's response to the stimulation. This personalized titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.


Find Patent Forward Citations

Loading…